Literature DB >> 21195930

Indoxyl sulfate reduces klotho expression and promotes senescence in the kidneys of hypertensive rats.

Ayinuer Adijiang1, Hidehisa Shimizu, Yusuke Higuchi, Fuyuhiko Nishijima, Toshimitsu Niwa.   

Abstract

BACKGROUND: Administration of indoxyl sulfate, a uremic toxin, promotes progression of chronic kidney disease in rats affected by the disease. Klotho, an anti-aging gene, is expressed in the kidneys, and its renal expression is decreased in chronic kidney disease. This study aimed to clarify whether indoxyl sulfate could reduce klotho expression and contribute to cell senescence in the kidneys of hypertensive rats.
METHODS: The rats used for this study were segregated in to the following 4 groups: (1) Dahl salt-resistant normotensive rats (DN), (2) Dahl salt-resistant normotensive indoxyl sulfate-administered rats (DN + IS), (3) Dahl salt-sensitive hypertensive rats (DH), and (4) Dahl salt-sensitive hypertensive indoxyl sulfate-administered rats (DH + IS). After 32 weeks, their kidneys were excised for histological and immunohistochemical analysis for klotho, senescence-associated β-galactosidase, p16(INK4a), p21(WAF1/CIP1), p53, and retinoblastoma protein (Rb).
RESULTS: DH + IS rats showed decreased expression of klotho, increased expression of senescence-associated β-galactosidase, p16(INK4a), p21(WAF1/CIP1), p53, and Rb in renal tubular cells, and increased tubulointerstitial fibrosis and mesangial expansion as compared with DH rats. Further, DN + IS rats showed decreased expression of klotho as compared with DN rats.
CONCLUSION: Administration of indoxyl sulfate to hypertensive rats reduced renal expression of klotho and promoted cell senescence with expression of senescence-related proteins, such as p16(INK4a), p21(WAF1/CIP1), p53, and Rb, which was accompanied by renal fibrosis.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21195930     DOI: 10.1053/j.jrn.2010.10.020

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  23 in total

Review 1.  Klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

Review 2.  Secreted klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 3.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

Review 4.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

Review 5.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

Review 6.  Protein-bound uremic toxins: new insight from clinical studies.

Authors:  Sophie Liabeuf; Tilman B Drüeke; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2011-07-20       Impact factor: 4.546

7.  Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.

Authors:  Chiao-Yin Sun; Shih-Chung Chang; Mai-Szu Wu
Journal:  Kidney Int       Date:  2012-01-11       Impact factor: 10.612

8.  Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition.

Authors:  Chiao-Yin Sun; Shih-Chung Chang; Mai-Szu Wu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-β1-receptor signaling.

Authors:  Cody C Gifford; Fei Lian; Jiaqi Tang; Angelica Costello; Roel Goldschmeding; Rohan Samarakoon; Paul J Higgins
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.191

10.  Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.

Authors:  Dilinaer Bolati; Hidehisa Shimizu; Maimaiti Yisireyili; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  BMC Nephrol       Date:  2013-03-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.